Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age

Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age

<b>Background:</b> Immune checkpoint inhibitors (ICI) have transformed the management of various cancers. Serious and potentially fatal cardiovascular toxicity, as well as a progression of atherosclerosis, have been described, mainly in elderly and comorbid patients. <b>Methods:<...

Full description

Bibliographic Details
Main Authors: Raffaella Calabretta, Philipp B. Staber, Christoph Kornauth, Xia Lu, Patrick Binder, Verena Pichler, Markus Mitterhauser, Alexander Haug, Xiang Li, Marcus Hacker
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Biology
Subjects:
atherosclerosis
cardiovascular toxicity
cardio-oncology
immune checkpoint inhibitor
PET
Online Access:https://www.mdpi.com/2079-7737/10/11/1206

Similar Items

Similar Items